Skip to main content

Descriptors for Protein Sequences?


Does anyone know of a website/web service that calculates a series of descriptors of a protein sequence, analogous to the descriptors that are regularly calculated for small molecules.

Specifically what I'm looking for is something that gives a large set of descriptors for either a sequence, or for a given stable identifier (e.g. UniProt ID). The descriptors I'd like back would be things like Molecular weight, number of each amino acid, fraction of each amino acid, hydrophobicity values, complexity/sequence entropy values, number of transmembrane helices, presence of certain features (e.g. signal sequence, nuclear localisation sequence, etc.), domain counts would be good as well - building up a 'fingerprint' for the sequence. I guess with a little bit of thought, it would be possible to come up with a fuller list of descriptors, and the above certainly isn't exclusive, but you get the idea; I'm sure. To be clear, I don't want an annotation service, I just want some numerical/logical feature descriptors.

Does something like this exist, should it be built if not, and so forth?

Comments

Di and tripeptides generated from sequence are the most simple one, and I think you don't need a web serive for that. It's quit easy to implement.
jpo said…
You're right, for small peptides it is quite straightforward to enumerate, and then calculate classical small molecule type features, but what I am after is a set of descriptors for arbitrary length sequences, and that have more 'biological context' - a sort of 'functional group' sort of analogue.
John, the CDK has some protein descriptors, and MW can be done too, and AA count is not there but trivial. What is the input? The sequence, a PDB id or a PDB file?
Matteo Floris said…
Pepstats is a command line tool from the EMBOSS suite which is a source of descriptors: http://emboss.sourceforge.net/apps/cvs/emboss/apps/pepstats.html
Unknown said…
You could try our R package protr: http://cran.r-project.org/web/packages/protr/ or the web app ProtrWeb: http://cbdd.csu.edu.cn:8080/protrweb/ . They provide several state-of-the-art protein sequence-derived structural and physicochemical descriptors. : )

Popular posts from this blog

Improvements in SureChEMBL's chemistry search and adoption of RDKit

    Dear SureChEMBL users, If you frequently rely on our "chemistry search" feature, today brings great news! We’ve recently implemented a major update that makes your search experience faster than ever. What's New? Last week, we upgraded our structure search engine by aligning it with the core code base used in ChEMBL . This update allows SureChEMBL to leverage our FPSim2 Python package , returning results in approximately one second. The similarity search relies on 256-bit RDKit -calculated ECFP4 fingerprints, and a single instance requires approximately 1 GB of RAM to run. SureChEMBL’s FPSim2 file is not currently available for download, but we are considering generating it periodicaly and have created it once for you to try in Google Colab ! For substructure searches, we now also use an RDKit -based solution via SubstructLibrary , which returns results several times faster than our previous implementation. Additionally, structure search results are now sorted by

Improved querying for SureChEMBL

    Dear SureChEMBL users, Earlier this year we ran a survey to identify what you, the users, would like to see next in SureChEMBL. Thank you for offering your feedback! This gave us the opportunity to have some interesting discussions both internally and externally. While we can't publicly reveal precisely our plans for the coming months (everything will be delivered at the right time), we can at least say that improving the compound structure extraction quality is a priority. Unfortunately, the change won't happen overnight as reprocessing 167 millions patents takes a while. However, the good news is that the new generation of optical chemical structure recognition shows good performance, even for patent images! We hope we can share our results with you soon. So in the meantime, what are we doing? You may have noticed a few changes on the SureChEMBL main page. No more "Beta" flag since we consider the system to be stable enough (it does not mean that you will never

ChEMBL brings drug bioactivity data to the Protein Data Bank in Europe

In the quest to develop new drugs, understanding the 3D structure of molecules is crucial. Resources like the Protein Data Bank in Europe (PDBe) and the Cambridge Structural Database (CSD) provide these 3D blueprints for many biological molecules. However, researchers also need to know how these molecules interact with their biological target – their bioactivity. ChEMBL is a treasure trove of bioactivity data for countless drug-like molecules. It tells us how strongly a molecule binds to a target, how it affects a biological process, and even how it might be metabolized. But here's the catch: while ChEMBL provides extensive information on a molecule's activity and cross references to other data sources, it doesn't always tell us if a 3D structure is available for a specific drug-target complex. This can be a roadblock for researchers who need that structural information to design effective drugs. Therefore, connecting ChEMBL data with resources like PDBe and CSD is essen

ChEMBL 34 is out!

We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains:         2,431,025 compounds (of which 2,409,270 have mol files)         3,106,257 compound records (non-unique compounds)         20,772,701 activities         1,644,390 assays         15,598 targets         89,892 documents Data can be downloaded from the ChEMBL FTP site:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release:  https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.

In search of the perfect assay description

Credit: Science biotech, CC BY-SA 4.0 Assays des cribe the experimental set-up when testing the activity of drug-like compounds against biological targets; they provide useful context for researchers interested in drug-target relationships. Ver sion 33 of ChEMBL contains 1.6 million diverse assays spanning ADMET, physicochemical, binding, functional and toxicity experiments. A set of well-defined and structured assay descriptions would be valuable for the drug discovery community, particularly for text mining and NLP projects. These would also support ChEMBL's ongoing efforts towards an  in vitro  assay classification. This Blog post will consider the features of the 'perfect' assay description and provide a guide for depositors on the submission of high quality data. ChEMBL's assays are typically structured with the overall aim, target, and method .  The ideal assay description is succinct but contains all the necessary information for easy interpretation by database u